Related Experiment Video

Updated: Nov 22, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.7K

Cancer immunotherapy with T-cell targeting cytokines: IL-2 and IL-7

Ji-Hae Kim1, Kun-Joo Lee2, Seung-Woo Lee3

  • 1Department of Life Sciences, Pohang University of Science and Technology (POSTECH), Pohang 37673, Korea.

BMB Reports
|January 7, 2021
PubMed

Insights

Interleukin (IL)-2 and IL-7 cytokines show promise in cancer immunotherapy by enhancing T-cell responses. Research explores improving these cytokines and combining them with other treatments for better patient outcomes.

Area of Science:

  • Immunology
  • Oncology
  • Biochemistry

Background:

  • Increased effector T cells correlate with better cancer patient prognosis.
  • Checkpoint inhibitors (CPIs) have advanced cancer immunotherapy but have limitations for patients lacking T cells or CPI targets.
  • Interleukin (IL)-2 and IL-7 are cytokines crucial for T-cell responses and have been investigated for cancer treatment.

Purpose of the Study:

  • To review the fundamental biology of IL-2 and IL-7 in regulating T-cell responses.
  • To summarize clinical trials investigating IL-2 and IL-7 for cancer treatment.
  • To explore strategies for enhancing cytokine activity and combining them with other therapies.

Main Methods:

  • Literature review of basic cytokine biology.
  • Analysis of clinical trial data for IL-2 and IL-7 in cancer.
  • Synthesis of recent research on cytokine modification and combination therapies.

Main Results:

  • IL-2 and IL-7 play significant roles in modulating T-cell immunity.
  • Clinical trials show varying efficacy of IL-2 and IL-7 in cancer treatment.
  • Emerging studies focus on optimizing cytokine function and synergistic combination strategies.

Conclusions:

  • IL-2 and IL-7 are important cytokines for T-cell-based cancer immunotherapy.
  • Further research is needed to overcome limitations and enhance the efficacy of cytokine-based therapies.
  • Combination strategies hold potential for improving treatment outcomes in cancer patients.

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.0K
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

1.4K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
876
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
628
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.3K